Literature DB >> 12914678

Vaccine trial in Alzheimer's disease is halted.

Karen Marder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12914678     DOI： 10.1007/s11910-003-0018-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  10 in total

Review 1.  beta-peptide immunization: a possible new treatment for Alzheimer disease.

Authors:  D B Schenk; P Seubert; I Lieberburg; J Wallace
Journal:  Arch Neurol       Date:  2000-07

Review 2.  Alzheimer's disease and Parkinson's disease.

Authors:  Robert L Nussbaum; Christopher E Ellis
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

3.  Alzheimer disease's double-edged vaccine.

Authors:  S M Greenberg; B J Bacskai; B T Hyman
Journal:  Nat Med       Date:  2003-03-17       Impact factor: 53.440

4.  Nerve inflammation halts trial for Alzheimer's drug.

Authors:  Erika Check
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

Authors:  J McLaurin; R Cecal; M E Kierstead; X Tian; A L Phinney; M Manea; J E French; M H L Lambermon; A A Darabie; M E Brown; C Janus; M A Chishti; P Horne; D Westaway; P E Fraser; H T J Mount; M Przybylski; P St George-Hyslop
Journal:  Nat Med       Date:  2002-10-15       Impact factor: 53.440

6.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

Review 7.  Immunization treatment approaches in Alzheimer's and prion diseases.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

8.  Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

Authors:  James A R Nicoll; David Wilkinson; Clive Holmes; Phil Steart; Hannah Markham; Roy O Weller
Journal:  Nat Med       Date:  2003-03-17       Impact factor: 53.440

9.  Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease.

Authors:  C F Lippa; L E Nee; H Mori; P St George-Hyslop
Journal:  Lancet       Date:  1998-10-03       Impact factor: 79.321

Review 10.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.